This approach could transform radiation therapy by allowing higher doses to be used more safely, ultimately improving outcomes for cancer patients.

Research reveals promising advancements of Ce6-GFFY in colorectal cancer treatment. Colorectal cancer (CRC) is a highly malignant disease that readily metastasizes to vital organs. Many strategies ...

Manipulating the immune system to treat cancer has generated phenomenal responses in some patients, including complete cures, ...

therapies. But while health care providers can now successfully develop drugs that use dsRNA to accurately target and silence disease-causing genes, a major challenge remains: getting these ...

More widespread use of mammograms, along with the implementation of targeted hormone therapies more than 40 years ago, has ...

A new review published in Genes & Diseases explores the pivotal role of the ubiquitin-proteasome system (UPS) in regulating the tumor microenvironment (TME) and driving cancer progression. The study ...

Colorectal cancer (CRC) is a highly malignant disease that readily metastasizes to vital organs. Many strategies have been employed for clinical CRC therapy.

where it is taken up by tumor cells that then express tumor suppressor proteins that were deficient in the tumor. The Company's lead product candidate, Reqorsa® Gene Therapy (quaratusugene ozeplasmid) ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

Genprex’s (GNPX) research collaborators at a major cancer research center in Houston, Texas have published a new study which used the company’s ...

The agreement, announced on Wednesday, focuses on the advancement of tumor-activated immunotherapies ... continues to advance a dynamic pipeline of investigational therapies. Xilio Therapeutics ...